Engineering of a parainfluenza virus type 5 fusion protein (PIV-5 F): development of an autonomous and hyperfusogenic protein by a combinational mutagenesis approach
- PMID: 19770012
- DOI: 10.1016/j.virusres.2009.09.009
Engineering of a parainfluenza virus type 5 fusion protein (PIV-5 F): development of an autonomous and hyperfusogenic protein by a combinational mutagenesis approach
Abstract
The entry of enveloped viruses into host cells is accomplished by fusion of the viral envelope with the target cell membrane. For the paramyxovirus parainfluenza virus type 5 (PIV-5), this fusion involves an attachment protein (HN) and a class I viral fusion protein (F). We investigated the effect of 20 different combinations of 12 amino-acid substitutions within functional domains of the PIV-5 F glycoprotein, by performing cell surface expression measurements, quantitative fusion and syncytia assays. We found that combinations of mutations conferring an autonomous phenotype with mutations leading to an increased fusion activity were compatible and generated functional PIV-5 F proteins. The addition of mutations in the heptad-repeat domains led to both autonomous and hyperfusogenic phenotypes, despite the low cell surface expression of the corresponding mutants. Such engineering approach may prove useful not only for deciphering the fundamental mechanism behind viral-mediated membrane fusion but also in the development of potential therapeutic applications.
Similar articles
-
Proper spacing between heptad repeat B and the transmembrane domain boundary of the paramyxovirus SV5 F protein is critical for biological activity.Virology. 1997 Dec 22;239(2):327-39. doi: 10.1006/viro.1997.8917. Virology. 1997. PMID: 9434724
-
Conserved leucine residue in the head region of morbillivirus fusion protein regulates the large conformational change during fusion activity.Biochemistry. 2009 Sep 29;48(38):9112-21. doi: 10.1021/bi9008566. Biochemistry. 2009. PMID: 19705836
-
Peptides corresponding to the heptad repeat sequence of human parainfluenza virus fusion protein are potent inhibitors of virus infection.Virology. 1996 Sep 1;223(1):103-12. doi: 10.1006/viro.1996.0459. Virology. 1996. PMID: 8806544
-
Viral glycoprotein-mediated cell fusion assays using vaccinia virus vectors.Methods Mol Biol. 2004;269:309-32. doi: 10.1385/1-59259-789-0:309. Methods Mol Biol. 2004. PMID: 15114023 Review.
-
Determinants of organ tropism of sendai virus.Front Biosci. 1999 Oct 1;4:D642-5. doi: 10.2741/tashiro. Front Biosci. 1999. PMID: 10502551 Review.
Cited by
-
Identification of domains on the fusion (F) protein trimer that influence the hemagglutinin-neuraminidase specificity of the f protein in mediating cell-cell fusion.J Virol. 2011 Apr;85(7):3153-61. doi: 10.1128/JVI.01666-10. Epub 2011 Jan 26. J Virol. 2011. PMID: 21270148 Free PMC article.
-
Characterization of a key residue for hyperfusogenic phenotype in human parainfluenza virus type 2 (hPIV-2) fusion glycoprotein.Virus Genes. 2013 Oct;47(2):365-9. doi: 10.1007/s11262-013-0932-0. Epub 2013 Jun 8. Virus Genes. 2013. PMID: 23749102
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources